Radiation therapy for thyroid cancer that has spread
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests a precise type of radiation therapy (SBRT) for thyroid cancer that has spread to a few other parts of the body. It may help control those spots when other treatments haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have thyroid cancer and it has spread to no more than 5 other areas in your body.
- You have tried at least one type of treatment before, like radioactive iodine, targeted therapy, or immunotherapy.
- You are between 18 and 70 years old.
- You are generally healthy enough to be up and about (KPS score of 70 or more).
- Your blood counts and liver or kidney function are within the required ranges.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether giving radiation therapy after thyroid surgery can help destroy any leftover cancer cells in people with high-risk differentiated thyroid cancer. It is for those who had surgery but some cancer was still left behind.
This trial tests whether a precise type of radiation called SBRT can control lung cancer that has started to grow in only a few new spots while you are on standard treatments. It may help you delay changing to a different treatment.
This trial tests whether adding a special type of radiation (SBRT) can help people whose breast cancer did not shrink after two rounds of standard chemotherapy. It's for people with stage II or III breast cancer that is still growing or stable.
This study is comparing two different ways of giving radiation therapy for anaplastic and poorly differentiated thyroid cancer. The goal is to see which method is more effective in treating the cancer.
This trial combines a special high-dose radiation (SBRT) with immunotherapy to treat esophageal cancer that has spread to a few spots in the body (up to 5 spots in up to 3 organs). The goal is to see if this approach can better control the cancer.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
Hear when a new Thyroid Cancer Stage IV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.